India's MedPlus Health falls as unit gets drug license suspension order
** Shares of MedPlus Health Services MEDP.NS fall as much
as 4.3% to 811 rupees before recovering slightly; last down 3.8%
** Co's unit Optival Health Solutions gets suspension order
of drug license for stores in Karnataka and Maharashtra
** Stock on track for second-sharpest intraday fall in 2024
** Avg rating of six analysts is a "strong buy" and median
PT is 915 rupees, ~12% higher than current price - LSEG data
** Stock trims YTD gains to around 9%
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))
Recent news on MedPlus Health Services
See all newsBrief: Medplus Health Services Keeps Food Park And Concierge Health Facility Capex In Abeyance
India's Medplus Health Services set for worst day on record as Q1 profit plunges
India's MedPlus Health first quarter profit drops as expansion costs and competition weigh
Brief: Medplus Health Services Says Optival Health Solutions Receives Suspension Order For Drug License Of Store In Karnataka
Brief: Medplus Health Services Says Unit Optival Health Solutions Receives Three Drug License Suspension Orders In Karnataka And Andhra Pradesh